Roche revenue depressed by plummeting Tamiflu sales
October 15, 2010Sales and Marketing 2010 financials, Q3, Roche
Roche suffered a 3% drop in group revenue in the third quarter as sales of its Tamiflu plummeted by 90 …
Contract research news in brief
October 15, 2010Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis
Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …
Pharma-academia links under ‘greater scrutiny’
October 15, 2010Medical Communications Recognition Academy, academia, industry relations, industry reputation
A company aiming to form a bridge between health providers and the pharma sector has warned that academics and clinicians …
Orital appoints Andy Yeoman
October 15, 2010Business Services, Medical Communications Orital, appointment, medical communications
Andy Yeoman has joined digital healthcare consultancy Orital as a managing consultant.He has 20 years experience of working with the …
Government drops generic substitution plans
October 15, 2010Sales and Marketing NHS, generics, government
The coalition government has dropped plans to implement generic substitution in England. The Pharmaceutical Price Regulation Scheme (PPRS), a scheme …
PAN boosts account handling team
October 15, 2010Medical Communications Pan, appointment, medical communications
UK advertising agency PAN has made two new appointments and three promotions.Andisheh Thomson joins as account manager and Natalie Enniks …
Celgene completes Abraxis takeover
October 15, 2010Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology
Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …
Video exclusive: PM Society Digital Awards 2010
October 14, 2010Medical Communications PM Society Digital Awards, awards, digi, pm society
Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …
Researchers unearth Pfizer’s buried data
October 14, 2010Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data
Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
Philip Loder joins Alpha-Plus Medical Communications
October 14, 2010Medical Communications Alpha-Plus, Alpha-Plus Medical Communications, Client Service Director, appointment, fishawack, medical communications
High Wycombe, UK-based Alpha-Plus Medical Communications has appointed Dr Phil Loder as client service director. He has 16 years of …
Pharma manufacturing news in brief
October 14, 2010Manufacturing and Production Accucaps, Fresenius Kabi, ImmunoCellular Therapeutics, Laureate Pharma, SAFC Pharma
This week’s round-up of pharmaceutical manufacturing news includes a recall for Fresenius Kabi, facility updates from SAFC and Laureate Pharma …
NICE rejects GSK Tyverb appeal
October 14, 2010Sales and Marketing GlaxoSmithKline, NICE, Tyverb
NICE’s independent appeal board has ruled the UK drug’s watchdog did not exceed its powers when issuing guidance on GlaxoSmithKline’s …
Merck Serono eyes ‘Nanobody’ potential in rheumatology
October 14, 2010Research and Development Ablynx, Merck Serono
Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
UK invests £50m in targeted research
October 13, 2010Research and Development BIA, clinical research, genomics, personalised medicine, targeting
The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
China driving global pharma growth
October 13, 2010Sales and Marketing China, emerging markets, sales
The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …
Pfizer acquires King Pharmaceuticals for $3.6bn
October 13, 2010Sales and Marketing King Pharmaceuticals, Pfizer, pain therapeutics
Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …
NICE unmoved on Takeda bone cancer drug
October 13, 2010Sales and Marketing Mepact, NICE, Takeda
NICE has refused to recommend Takeda’s Mepact because of its “exceptionally high cost” and the “substantial uncertainty” about the osteosarcoma …
Philip Vickers joins Shire
October 13, 2010Research and Development Shire, appointment, research and development
Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Digital Pharma: Genzyme’s augmented reality heart
October 12, 2010Medical Communications Digital Pharma blog, Genzyme, augmented reality
Genzyme Europe has launched a new website that allows users to take a peak inside their own heart, or so …
Pharmsynthez boosts board
October 12, 2010Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development
Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
